HealthDay News — A machine learning model can make accurate survival predictions for Merkel cell carcinoma (MCC), according to a study published online Jan. 8 in npj Digital Medicine.
Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study In this pilot study, we assessed the adoptive T-cell ...
Keytruda is also indicated for the treatment of patients with unresectable or metastatic melanoma, for the treatment of patients with metastatic non-small cell lung cancer (NSCLC ... with stage III ...
WEDNESDAY, Jan. 15, 2025 (HealthDay News) -- A machine learning model can make accurate survival predictions for Merkel cell carcinoma (MCC), according to a study published online Jan. 8 in npj ...
The FDA has approved the investigational new drug application of 225Ac-SSO110, allowing for the start of a phase 1/2 trial in patients with extensive-stage small cell lung cancer and Merkel cell ...
WEDNESDAY, Jan. 15, 2025 (HealthDay News) — A machine learning model can make accurate survival predictions for Merkel cell carcinoma (MCC), according to a study published online Jan. 8 in npj Digital ...
In thyroid cancer, particularly papillary thyroid carcinoma, lymph node metastases are common, and extranodal extension can influence prognosis and treatment decisions. The challenges in diagnosing ...
in patients with small cell lung cancer (SCLC) or Merkel Cell Carcinoma (MCC). The SANTANA-225 trial is a global, open-label Phase I/II study, that will assess the safety, tolerability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback